Diagnostic approach in suspected recurrent primary brain tumors using 18FDG-PET/MRI, perfusion MRI, visual and quantitative analysis, and three dimensional stereotactic surface projections. First experience in Mexico

Revista Espanola de Medicina Nuclear

Volumn 27, Issue 5, 2008, Pages 329-339

  Estrada Sanchez G ^a,b,e   Gonzalez Maya L ^b   Celis Lopez M A ^c   Gavito, J ^c   Larraga Gutierrez J M ^c   Salgado, P ^c   Altamirano, J ^b,d  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DEL ESTADO DE MORELOS   (Mexico)

^c NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^d INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^e CT Scanner Diagnostic Imaging Center   (Mexico)

Author keywords

3D SSP; Brain tumors; Perfusion MRI; PET MRI fusion

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOLINIUM;

ADULT; AGED; ARTICLE; BLOOD VOLUME; BRAIN CIRCULATION; BRAIN CORTEX; BRAIN TUMOR; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DRUG UPTAKE; FALSE POSITIVE RESULT; FEMALE; FOREIGN BODY GRANULOMA; GLUCOSE TRANSPORT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MEXICO; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; STEREOTACTIC PROCEDURE; THREE DIMENSIONAL IMAGING; TUMOR RECURRENCE;

EID: 55549128926     PISSN: 02126982     EISSN: 1578200X     Source Type: Journal    
DOI: 10.1157/13126189     Document Type: Article

References (45)

1. O'Doherty. Positron emission Tomography: A strategy for provision in the UK. A report of the Intercollegiate Standing Committee on Nuclear Medicine. Royal College of Physicians of London; 2003. p. 1-41.
2. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathology. 1993;3:255-68.
3. a ed. México, D.F.: Ed. McGraw Hill; 2003. p. 675-82.
4. Matthews PM, Wylezinska M, Cadoux-Hudson T. Novel approaches to imaging brain tumors. Hematol Oncol Clin North Am. 2001;15:1534-602.
5. Purdy AR, Kirby S. Headaches and brain tumors. Neurol Clin. 2004;22:1796-824.
6. Tam Truong M. Current role of radiation therapy in the management of malignant brain tumors. Hematol Oncol Clin North Am. 2006;20:431-53.
7. Tanaka M, Ino Y, Nakagawa K, Tago M, Todo T. High-dose conformal radiotherapy for supratentorial malignant glioma: a historical comparison. Lancet Oncol. 2005;6:953-60.
8. Levivier M, Wikier D, Goldman S, David P, Metens T, Massager M, et al. Integration of the metabolic data of positron emission tomography in the dosimeter planning o radiosurgery with the gama knife: early experience with brain tumors. J Neurosurg. 2000;93 Suppl 3:233-8.
9. Celis-López MA, Lárraga-Gutiérrez JM. Dedicated linac for radioneurosurgery at the INNyN of México. AIP Conf Proc. 2003;682:49-53.
10. Lárraga-Gutiérrez JM, Celis-López MA. First experience in intensity modulated radiosurgery at the INNyN of México. AIP Conf Proc. 2003;682:54-60.
11. Matheus MG, Castillo M, Ewend M, Smith JK, Knock L, Cush S, et al. CT and MRI imaging after placement of the GliaSite radiation therapy system to treat brain tumor: initial experience. AJNR Am J Neuroradiol. 2004;25:1211-7.
12. Newberg AB, Alavi A. The role of PET imaging in the management of patients with central nervous system disorders. Radiol Clin North Am. 2005;43:49-65.
13. Wang SX, Boethius J, Ericson K. FDG-PET on irradiated brain tumor: ten years' summary. Acta Radiol. 2006;47:85-90.
14. Covarrubias DJ, Rosen BR, Lev MH. Dynamic magnetic resonance perfusion imaging of brain tumors. Oncologist. 2004;9:528-37.
15. Law M, Young R, Babb J, Pollack E, Johnson G. Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas. AJNR Am J Neuroradiol. 2007;28:761-6.
16. a ed. México: Ed. Intersistemas; 2005. p. 19-29.
17. Altamirano-Ley LJ, Estrada-Sánchez GR. Aplicaciones oncológicas de la tomografía por emisión de positrones. Ann Rad Mex. 2005;4:323-31.
18. Borbély K, Nyáry I, Tóth M, Ericson K, Gulyás B. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas. J Neurol Sci. 2006;246:85-94.
19. Mosconi L, Wai Hon Tsui A, Pupi S, De Santi A, Drzezga S, Minoshima MJ, et al. 18F-FDG PET Database of longitudinally confirmed healthy elderly individuals improves detection of mild cognitive impairment and Alzheimer's disease. J Nucl Med. 2007;48:1129-34.
20. Hakyemez B, Erdogan C, Ercan I, Ergin N, Uysal S, Atahan S. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging. Clin Radiol. 2005;60:493-502.
21. Weber MA, Zoubaa S, Schlieter M, Juttler E, Huttner HB, Geletneky K, et al. Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors. Neurology. 2006;66:1899-906.
22. Studholme C, Hill DLG, Hawkes DJ. Automated three-dimensional fusion of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures. Med Phys. 1997;24:25-35.
23. Studholme C, Hill DLG, Hawkes DJ. An overlap invariant entropy measure of 3D medical image alignment. Pattern Recognit. 1999;32:71-86.
24. Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med. 1995;36:1238-48.
25. Hustinx R, Pourdehnad M, Kaschten B, Alavi A. PET imaging for differentiating recurrent brain tumor from radiation necrosis. Radiol Clin North Am. 2005;43:35-47.
26. Chen W. Clinical applications of PET in brain tumors. J Nucl Med. 2007;48:1468-81.
27. Mosconi L, Tsui WH, De Santi S, Li J, Rusinek H, Convit A, et al. Reduced hippocampal metabolism in MCI and AD automated FDG-PET image analysis. Neurology. 2005;64:1860-7.
28. Chen W, Silverman DHS, Delaloye S, Czernin J, Kamdar N, Pope W, et al. 18F-FDOPA PET Imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy. J Nucl Med. 2006;47:904-11.
29. Zhuang H, Yu JQ, Alavi A. Applications of fluorodeoxyglucose-PET imaging in the detection of infection and inflammation and other benign disorders. Radiol Clin North Am. 2005;43:121-34.
30. Fischman AJ, Thornton AF, Frosch MP, Swearinger B, Gonzalez RG, Alpert NM, et al. FDG hypermetabolism associated with inflammatory necrotic changes following radiation of meningioma. J Nucl Med. 1997;38:1027-9.
31. Dadparvar S, Anderson GS, Bhargava P, Guan L, Reich P, Alavi A, et al. Paraneoplastic encephalitis associated with cystic teratoma is detected by fluorodeoxyglucose positron emission tomography with negative magnetic resonance image findings. Clin Nucl Med. 2003;28:893-6.
32. Herholz K, Coope D, Jackson A. Metabolic and molecular imaging in neuro-oncology. Lancet Neurol. 2007;6:711-24.
33. Wong TZ. Positron emission tomography imaging of brain tumors. Neuroimaging Clin N Am. 2002;12:615-26.
34. Sauvageot CM, Kesari S, Stiles CD. Molecular pathogenesis of adult brain tumors and the role of stem cells. Neurol Clin. 2007;25:891-924.
35. Preul C, Kühn B, Lang EW, Mehdorn HM, Heller M, Link J. Differentiation of cerebral tumors using multi-section echo planar MR perfusion imaging. Eur J Radiol. 2003;48:244-51.
36. Leimgruber A, Ostermann S, Yeon EJ, Buff E, Maeder PP, Stupp R, et al. Perfusion and diffusion MRI of glioblastoma progression in a four-year prospective temozolomide clinical trial. Int J Radiat Oncol Biol Phys. 2006;64:869-75.
37. Deb P, Sharma MC, Mahapatra AK, Agarwal D, Sarkar C. Glioblastoma multiforme with long term survival. Neurol India. 2005;53:329-32.
38. Steinbach JP, Blaicher HP, Herrlinger U, Wick W, Nagele T, Meyermann R, et al. Surviving glioblastoma for more than 5 years: the patient's perspective. Neurology. 2006;66:239-42.
39. Mangiola A, Maira G, De Bonis P, Porso M, Pettorini B, Sabatino G, et al. Glioblastoma multiforme in the elderly: a therapeutic challenge. J Neurooncol. 2006;76:159-63.
40. Stark AM, Nabavi A, Mehdorn HM, Blömer U. Glioblastoma multiforme-report of 267 cases treated at a single institution. Surg Neurol. 2005;63:162-9.
41. Catana C, Wu Y, Judenhofer MS, Qi Ji, Pichler BJ, Cherry SR. Simultaneous acquisition of multislice PET and MR images: initial results with a MR-compatible PET scanner. J Nucl Med. 2006;47:1968-76.
42. Kiebel SJ, Ashburner J, Poline JB, Friston KJ. MRI and PET coregistration - a cross validation of statistical parametric mapping and automated image registration. Neuroimage. 1997;5:271-9.
43. García-Garduño OA, Lárraga-Gutiérrez JM, Celis MA, Suárez-Campos JJ, Rodríguez-Villafuerte M, Martínez-Dávalos A. Assessment of geometrical accuracy of multimodal images used for treatment planning in stereotactic radiotherapy and radiosurgery. AIP Conf Proc. 2006;854:104.
44. Wyss MT, Spaeth N, Biollaz G, Pahnke J, Alessi P, Trachsel E, et al. Uptake of 18F-fluorocholine, 18F-FET, and 18F-FDG in C6 gliomas and correlation with 131I-SIP(L19), a marker of angiogenesis. J Nucl Med. 2007;48:608-14.
45. Hsu AR, Cai W, Veeravagu A, Mohamedali KA, Chen K, Kim S, et al. Multimodality molecular imaging of glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121/rGel. J Nucl Med. 2007;48:445-54.